Cogent Biosciences Operating Margin Growth & History (COGT)

Cogent Biosciences's operating margin was −1,044.33% for fiscal 2020.

View full Cogent Biosciences company overview

Cogent Biosciences annual operating margin history

Cogent Biosciences annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20202020-12-31−1,044.33%−901.31 pp
20192019-12-31−143.02%+226.87 pp
20182018-12-31−369.89%−57.07 pp
20172017-12-31−312.82%

Cogent Biosciences operating margin trends

Across the available reported history, Cogent Biosciences's operating margin decreased from −143.02% to −1,044.33%, a change of −901.31 percentage points. The latest reported quarter, Q3 2020, shows −18,333.01%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cogent Biosciences filings at SEC.gov ↗